A Double-Blind, Placebo-Controlled, Parallel-Group Study

Project: Research project

Project Details

Description

A Double-Blind, Placebo-Controlled, Parallel-Group Study of Rufinamide Given as Adjunctive Therapy in Patients with refractory Partial Seizures
StatusFinished
Effective start/end date8/1/067/15/09

Funding

  • Eisai London Research Laboratories Ltd.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.